The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a potential advance. Unlike subcutaneous injections, this technique offers a less invasive way to provide GLP-1 https://dillanuuzz682831.blogsuperapp.com/41505433/glp-1-patches-a-novel-approach-to-blood-sugar-control